| 摘要 |
The present invention provides a method for screening, diagnosis or prognosis of acute coronary syndrome (ACS) in a mammalian subject, for determining the stage or severity of ACS in a mammalian subject, for identifying a mammalian subject at risk of developing ACS, or for monitoring the effect of therapy administered to a mammalian subject having ACS. The method comprises measuring the level of Urotensin II (UTN) in a sample of bodily fluid from the mammalian subject. The invention also provides a kit, immunoassay or device for carrying out the method. |
